Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

73.34 USD -0.55 (-0.74%)
Official Closing Price Updated: 7:00 PM EST, Dec 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,508,952
Open 74.09
Bid (Size) 73.22 (4)
Ask (Size) 73.49 (1)
Prev. Close 73.89
Today's Range 72.66 - 74.25
52wk Range 15.32 - 91.40
Shares Outstanding 2,531,374,696
Dividend Yield 3.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Hot Stocks To Buy Right Now? 3 Health Care Stocks To Know
Tags Market News
From StockMarket.com
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pediatric (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection
FDA Approves KEYTRUDA as Adjuvant Treatment for Adult and Pediatric (Age 12+) Patients With Stage IIB or IIC Melanoma Following Complete Resection 
From Business Wire News Releases

Performance

YTD
-9.41%
-9.41%
1 Month
-19.00%
-19.00%
3 Month
-3.47%
-3.47%
6 Month
+0.74%
+0.74%
1 Year
-10.50%
-10.50%

More News

Read More
Fighting for Health Equity From Inside the Health Care Industry
Tags Merck Health & Healthcare Diversity & Inclusion
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LLY, GILD, MRK)
Tags Finance Financial Market Business
From AB Newswire
5 Biotech Stocks For Your December 2021 Watchlist
Tags Market News
From StockMarket.com
Here's Why Merck Lost Nearly $40 Billion in Value During November
Tags PFE MRK Recent Press Releases
From Motley Fool
Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review
Tags Market News BMY Health Care
From Benzinga
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
Tags ADGI Market News MRK
From Motley Fool
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
Tags Biotech IBB Small Cap
From Benzinga
Here's Why The New Coronavirus Variant Won't Harm Pfizer's Stock
Tags PFE Recent Press Releases BNTX
From Motley Fool
Regeneron: Surfing on Covid, With More Under the Surface
Tags VTRS REGN MRK
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.